Therapeutics Acquisition Corp. vs 10X Capital Venture Acquisition Corp. II, risk disclosures compared

4topics both disclose

2only Therapeutics Acquisition Corp.

3only 10X Capital Venture Acquisition Corp. II

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Therapeutics Acquisition Corp.	10X Capital Venture Acquisition Corp. II
Internal Control	4	4
Restatement	2	4
Enforcement Action	1	3
Material Weakness	1	3

Only Therapeutics Acquisition Corp.

Topic	Filings
Ransomware	2
Regulatory Reporting	2

Only 10X Capital Venture Acquisition Corp. II

Topic	Filings
Artificial Intelligence	2
Business Continuity	1
Regulatory Investigation	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Therapeutics Acquisition Corp. · 10X Capital Venture Acquisition Corp. II · All companies